Literature DB >> 12381246

The Heart Protection Study: implications for clinical practice. The benefits of statin therapy do not come without financial cost.

Ian Hamilton-Craig.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12381246     DOI： 10.5694/j.1326-5377.2002.tb04877.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  4 in total

1.  Why are physicians so skeptical about positive randomized controlled clinical trials in critical care medicine?

Authors:  Jesús Villar; Lina Pérez-Méndez; Armando Aguirre-Jaime; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2004-11-23       Impact factor: 17.440

2.  Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk.

Authors:  F El Fakiri; M A Bruijnzeels; A W Hoes
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

3.  Bedside adherence to clinical practice guidelines in the intensive care unit: the TECLA study.

Authors:  Jean-Pierre Quenot; Hervé Mentec; François Feihl; Djillali Annane; Christian Melot; Philippe Vignon; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2008-03-26       Impact factor: 17.440

Review 4.  Perspective of synaptic protection after post-infarction treatment with statins.

Authors:  Johanna Andrea Gutiérrez-Vargas; Angel Cespedes-Rubio; Gloria Patricia Cardona-Gómez
Journal:  J Transl Med       Date:  2015-04-13       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.